Synthetic Biology and Its Potential in U.S. Medical Therapeutics: A Comprehensive Review: Exploring the Cutting-Edge Intersections of Biology and Engineering in Drug Development and Treatments.

References

[1] Akpoviri, F., Zainol, Z. A., & Baharum, S. N. (2020). Synthetic biology and biosafety governance in the European Union and the United States. IIUMLJ, 28, 37. DOI: 10.31436/iiumlj.v28i1.520

[2] Aldulijan, I., Beal, J., Billerbeck, S., Bouffard, J., Chambonnier, G., Ntelkis, N., Guerreiro, I., Holub, M., Ross, P., Selvarajah, V., Sprent, N., Vidal, G., & Vignoni, A. (2022). Functional Synthetic Biology. Synthetic Biology, 8(1), ysad006, https://doi.org/10.1093/synbio/ysad006

[3] Bibi, A., & Ahmed, A. (2020). Synthetic biology: Approaches, opportunities, applications and challenges. Abasyn Journal of Life Sciences, 3(2). DOI: 10.34091/ajls.3.2.3

[4] Boghossian, A. A. (2022). (Nanocarbons Division SES Young Investigator Award) Synthetic Biology Approaches for Overcoming Bottlenecks in Optical Nanocarbon Technologies. In Electrochemical Society Meeting Abstracts 241, No. 8, pp. 677-677. The Electrochemical Society, Inc. DOI: 10.1149/ma2022-018677mtgabs.

[5] Boehm, C. R., & Bock, R. (2019). Recent advances and current challenges in synthetic biology of the plastid genetic system and metabolism. Plant Physiology, 179(3), 794-802. https://doi.org/10.1104/pp.18.00767

[6] Bojar, D., & Fussenegger, M. (2020). The role of protein engineering in biomedical applications of mammalian synthetic biology. Small, 16(27), 1903093. DOI: 10.1002/smll.201903093

[7] Brooks, S. M., & Alper, H. S. (2021). Applications, challenges, and needs for employing synthetic biology beyond the lab. Nature Communications, 12(1), 1390. DOI: 10.1038/s41467-021-21740-0

[8] Buecherl, L., & Myers, C. J. (2022). Engineering genetic circuits: advancements in genetic design automation tools and standards for synthetic biology. Current opinion in microbiology, 68, 102155. DOI: 10.1016/j.mib.2022.102155

[9] Cruz, K. C. P., Enekegho, L. O., & Stuart, D. (2022). Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases. Frontiers in Bioengineering and Biotechnology, 10. DOI: 10.3389/fbioe.2022.890479.

[10] David, F., Davis, A. M., Gossing, M., Hayes, M. A., Romero, E., Scott, L. H., & Wigglesworth, M. J. (2021). A perspective on synthetic biology in drug discovery and development—current impact and future opportunities. SLAS DISCOVERY: Advancing the Science of Drug Discovery, 26(5), 581-603. DOI: 10.1177/24725552211000669

[11] Dixon, T. A., Walker, R. S., & Pretorius, I. S. (2023). Visioning synthetic futures for yeast research within the context of current global techno‐political trends. Yeast, 40(10), 443-456. DOI: 10.1002/yea.3897

[12] François, J. M., & Atsumi, S. (2023). Insights into synthetic biology 2021: Novel developments, current challenges, and future perspectives. Frontiers in Bioengineering and Biotechnology, 11, 1200227. DOI: 10.3389/fbioe.2023.1200227

[13] Gallup, O., Ming, H., & Ellis, T. (2021). Ten future challenges for synthetic biology. Engineering Biology, 5(3), 51-59. DOI: 10.1049/enb2.12011

[14] Jinming, C. U. I., Liwei, W. A. N. G., Zhiguang, C. H. A. N. G., Zhongsheng, Z. A. N. G., & Chenli, L. I. U. (2018). Progress of Synthetic Biology Research in Medical Applications. Bulletin of Chinese Academy of Sciences (Chinese Version), 33(11), 1218-1227. DOI: 10.1038/s41392-023-01440-5

[15] Khan, F. F. (2020). Pakistan—Synthetic Biology–Challenges and Opportunities from a Biodiversity Perspective in Pakistan. GMOs: Implications for Biodiversity Conservation and Ecological Processes, 585-590. DOI: 10.1007/978-3-030-53183-6_34

[16] Kiran, G. S., Ramasamy, P., Sekar, S., Ramu, M., Hassan, S., Ninawe, A. S., & Selvin, J. (2018). Synthetic biology approaches: Towards sustainable exploitation of marine bioactive molecules. International journal of biological macromolecules, 112, 1278-1288.

[17] Lee, S. J., & Kim, D.M. (2023). Cell-Free Synthetic Biology: Navigating the New Frontiers of Biomanufacturing and Biological Engineering. 37, 100488. DOI: 10.1016/j.coisb.2023.100488

[18] Lieneck, C., McLauchlan, M., Adachi, V., & Billings, R. (2023). Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs: A Narrative Review. Pharmacy, 11(6), 187. DOI: 10.3390/pharmacy11060187

[19] Lim, S., & Bayer, T. (2022). Engineering biology in the environment and sustainability. Engineering Biology, 6(1), 1. DOI: 10.1049/enb2.12019

[20] Lu, Y. (2020). An Introduction to Cell-Free Synthetic Biology. In: Cell-Free Synthetic Biology. Springer Briefs in Applied Sciences and Technology. Springer, Singapore. https://doi.org/10.1007/978-981-13-1171-0_1

[21] Mackelprang, R., & Lemaux, P. G. (2020). Genetic engineering and editing of plants: an analysis of new and persisting questions. Annual Review of Plant Biology, 71, 659-687. DOI: 10.1146/annurev-arplant-081519-035916

[22] Mao, N., Aggarwal, N., Poh, C. L., Cho, B. K., Kondo, A., Liu, C.,... & Chang, M. W. (2021). Future trends in synthetic biology in Asia. Advanced Genetics, 2(1), e10038. DOI: 10.1002/ggn2.10038

[23] Macovei, O. (2022). The Ethics of Synthetic Biology-at the Confluence of Ecoethics and Technoethics. Postmodern Openings, 13(3), 234-250. DOI: 10.18662/po/13.3/487

[24] Malik, M., & Undavia, J. N. (2020). Trials, Skills, and Future Standpoints of AI Based Research in Bioinformatics. International Journal of Recent Technology and Engineering (IJRTE), 9(1), 968-972. DOI:10.35940/ijrte.A1920.059120

[25] Mishra, A., & Pandey, N. (2023). Pricing information asymmetry in healthcare: stakeholder analysis and research insights. International Journal of Pharmaceutical and Healthcare Marketing, 17(4), 539-563. DOI: 10.1108/ijphm-01-2023-0010

[26] Mohammad, T., Hassan, M.I. (2018). Modern Approaches in Synthetic Biology: Genome Editing, Quorum Sensing, and Microbiome Engineering. In: Singh, S. (eds) Synthetic Biology. Springer, Singapore. https://doi.org/10.1007/978-981-10-8693-9_10

[27] Mohammad, T., Dahiya, R., Hassan, M.I. (2020). Implication of Synthetic Biology in Biotherapeutic Engineering. In: Singh, S. (eds) Systems and Synthetic Immunology. Springer, Singapore. pp. 245-253. https://doi.org/10.1007/978-981-15-3350-1_9.

[28] Palacios, D. S. (2022). Drug Hunting at the Nexus of Medicinal Chemistry and Chemical Biology and the Discovery of Novel Therapeutic Modalities. Journal of Medicinal Chemistry, 65(20), 13594-13613. DOI: 10.1021/acs.jmedchem.2c01491

[29] Pavlova, N., Miloshev, G. Y., Georgieva, A. V., Traykovska, M., & Penchovsky, R. (2022). Versatile tools of synthetic biology applied to drug discovery and production. Future Medicinal Chemistry, 14(18), 1325-1340. DOI: 10.4155/fmc-2022-0063.

[30] Perkins, M. L., Gandara, L., & Crocker, J. (2022). A synthetic synthesis to explore animal evolution and development. Philosophical Transactions of the Royal Society B, 377(1855), 20200517. DOI: 10.1098/rstb.2020.0517.

[31] Radic, M., Vosen, A., & Graf, B. (2019). Use of Robotics in the German Healthcare Sector: Application Scenarios-Drivers and Barriers–Time Savings. In Social Robotics: 11th International Conference, ICSR 2019, Madrid, Spain, November 26–29, 2019, Proceedings 11, pp. 434-442. Springer International Publishing. DOI: 10.1007/978-3-030-35888-4_40

[32] Rhodes, J.I., Mandivenyi, W. (2020). South Africa—Synthetic Biology Regulatory Considerations and Biodiversity – A Legal Perspective for South Africa. In: Chaurasia, A., Hawksworth, D.L., Pessoa de Miranda, M. (eds) GMOs. Topics in Biodiversity and Conservation. Springer, Cham. vol. 19, pp. 495-499. DOI: 10.1007/978-3-030-53183-6_24.

[33] Saha, S., Bhadana, D., Arya, R., Shah, P. K., & Kumar, P. (2023). An Overview of Bioinformatics and Computational Genomics in Modern Plant Science. International Journal of Environment and Climate Change, 13(9), 1530-1544. DOI: 10.9734/ijecc/2023/v13i92385.

[34] Spirov, A., & Myasnikova, E. (2019). Techniques from evolutionary computation to implement as experimental approaches in synthetic biology: tests in silico. In Proceedings of the Genetic and Evolutionary Computation Conference Companion, pp. 81-82. https://doi.org/10.1145/3319619.3326787

[35] Sun, H., & Zhong, Z. (2019). Biomacromolecules for Emerging Biological and Medical Science and Technology. Biomacromolecules, 20(12), 4241-4242. DOI: 10.1021/acs.biomac.9b01534.

[36] Sundaram, L. S., Ajioka, J. W., & Molloy, J. C. (2023). Synthetic Biology Regulation in Europe: Containment, Release, and Beyond. Synthetic Biology, ysad009.https://doi.org/10.1093/synbio/ysad009.

[37] Turpal, K. (2023). Synthetic biology as a breakthrough direction in the creation of biological systems. In BIO Web of Conferences, 76, 07002. EDP Sciences.

[38] https://doi.org/10.1051/bioconf/20237607002

[39] Wang, F. (2023). Synthetic Biology: From the Past to the Future. Academic Journal of Science and Technology, 5(2), 95-101. https://doi.org/10.54097/ajst.v5i2.6290

[40] Watson, J. (2022). Synthetic Biology: State Regulation in the Biomedical Context. American Journal of Law & Medicine, 48(4), 447-468. DOI: 10.1017/amj.2023.7

[41] Weidmann, A. G. (2018). Frontiers in CRISPR. ACS Chemical Biology, 13(2), 296-304. DOI: 10.1021/acschembio.8b00135

[42] Yan, X., Liu, X., Zhao, C., & Chen, G. Q. (2023). Applications of synthetic biology in medical and pharmaceutical fields. Signal Transduction and Targeted Therapy, 8(1), 199. DOI: 10.1038/s41392-023-01440-5

[43] Zhang, X. E., Liu, C., Dai, J., Yuan, Y., Gao, C., Feng, Y., ... & Si, T. (2023). Enabling technology and core theory of synthetic biology. Science China Life Sciences, 66, 1742-1785. DOI: 10.1007/s11427-022-2214-2.

[44] Zhao, N., Song, Y., Xie, X., Zhu, Z., Duan, C., Nong, C., ... & Bao, R. (2023). Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development. Signal Transduction and Targeted Therapy, 8(1), 112. DOI: 10.1038/s41392-023-01375-x

@article{1710264,
      author = {Abigael Kuponiyi, Opeoluwa Oluwanifemi Akomolafe, Olufunke Omotayo},
      title = {Synthetic Biology and Its Potential in U.S. Medical Therapeutics: A Comprehensive Review: Exploring the Cutting-Edge Intersections of Biology and Engineering in Drug Development and Treatments.},
      journal = {Iconic Research And Engineering Journals},
      year = {2023},
      volume = {7},
      number = {1},
      pages = {740-757},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1710264.pdf},
      abstract = {This study provides a comprehensive review of the cutting-edge intersections of biology and engineering in the realm of medical therapeutics, focusing on the advancements and applications of synthetic biology. The main objectives were to explore the historical evolution, define the scope, and analyze the current state-of-the-art in synthetic biology, particularly in drug development and treatment strategies. The methodology employed a systematic literature review and content analysis, utilizing a range of academic databases to gather relevant peer-reviewed articles published between 2013 and 2023. Key findings revealED that synthetic biology, through the integration of engineering principles and biological systems, has led to significant innovations in medical therapeutics. These include the development of novel drug delivery systems, targeted therapies, and personalized medicine approaches. The study highlights the challenges and limitations in current synthetic biology approaches, such as ethical concerns, regulatory hurdles, and the need for interdisciplinary collaboration. The future landscape of synthetic biology in medicine is marked by both challenges and prospects. The field holds immense potential for addressing complex diseases and enhancing healthcare delivery, yet faces significant challenges in ethical considerations and regulatory frameworks. Strategic recommendations are provided for researchers, industry leaders, and policymakers, emphasizing the need for continuous innovation, ethical applications, and comprehensive regulatory strategies. Finally, synthetic biology stands as a transformative force in medical therapeutics, with the potential to revolutionize healthcare. Future research should focus on overcoming current limitations and exploring new applications, ensuring the field's continued advancement and contribution to global healthcare.},
      keywords = {Synthetic Biology, Medical Therapeutics, Drug Development, Bioengineering},
      month = {July},
  }